MRF Conference 2017

Meningitis and septicaemia in children and adults 2017 14 and 15 November 2017 The British Museum, Great Russell St, Bloomsbury, London, WC1B 3DG, UK

Meningitis and Septicaemia in Children and Adults

14 and 15 November 2017
The British Museum, Great Russell St, Bloomsbury, London, WC1B 3DG, UK

Our eleventh conference will bring together internationally renowned experts from a range of specialties in the UK and abroad to address the most important issues of the day, including burden of illness, diagnosis, vaccine development, vaccine implementation and impact, and public health management and policy.

Attracting delegates from around the world, this conference is a key event in the calendar for some of the foremost scientists and clinicians and provides an excellent opportunity to discuss the latest developments within the field.

"Top class speakers.”

“This was extremely useful as education, to update clinically and add to my scientific knowledge. Thank-you”

“Really nice mix of academic and clinical lectures.”


We are also accepting poster abstracts to be considered for display at the conference here

Bookings now being taken


One day Non-commercial (£165) - For researchers working in an educational institute setting and health care professionals, not including for junior trainees (below the grade of specialty registrar) nurses, post-docs and those residing for more than 60% of the year in countries classified with low income and lower-middle income economies.

Two day Non-commercial (£260) - For researchers working in an educational institute setting and health care professionals, not including for junior trainees (below the grade of specialty registrar) nurses, post-docs and those residing for more than 60% of the year in countries classified with low income and lower-middle income economies.

One day commercial (£265) - For those working in a commercial environment, such as the pharmaceutical industry.
 
Two day commercial (£365) - For those working in a commercial environment, such as the pharmaceutical industry.
Book Now

One day discount (£115) - Discounted fees for junior trainees (below the grade of specialty registrar) nurses, post-docs and those residing for more than 60% of the year in countries classified with low income and lower-middle income economies.
Book Now

Two day discount (£185) - Discounted fees for junior trainees (below the grade of specialty registrar) nurses, post-docs and those residing for more than 60% of the year in countries classified with low income and lower-middle income economies.
Book Now

Or download and use our booking form to secure your place at conference
A.

Provisional programme:

Day 1 - Tuesday 14 November

  • Registration and Coffee
  • Welcome Vinny Smith, Chief Executive, Meningitis Research Foundation 

Valuing Life and Health - Putting People First
  • Patient experience of meningitis - Danny Sweatman, Member of Meningitis Research Foundation
  • Impacts from the MenB petition in the UK and the response from government - Dr Simon Nadel, St Mary's Hospital/Imperial College London
  • Vaccine decision making –are we asking the right questions? Discrete choice experiments - Dr Hannah Christensen, University of Bristol
  • Value of life and health: valuing the true impact of preventing life-threatening illnesses 
 
10.45-11.15 COFFEE, EXHIBITION AND POSTERS

Towards a world free from meningitis
  • Recent advances and remaining global challenges in control of meningococcal disease - Prof David Stephens, Emory University School of Medicine, USA
  • What next for prevention of pneumococcal disease in light of serotype replacement? Is there a pathway to licensure for novel pneumococcal vaccines? – Prof Richard Malley, Harvard Medical School, USA
  • Towards a global plan for defeating meningitis by 2030: outcomes from Meningitis in 2030 meeting - Introduced by Prof Sir Brian Greenwood, London School of Hygiene and Tropical Medicine; Dr Marie-Pierre Preziosi, World Health Organization, Geneva, Vinny Smith.
 
12:45-13:45 LUNCH, EXHIBITION AND POSTERS

Global Meningococcal Initiative.
Mass Gatherings and Meningococcal Disease; Panel Discussion Chair: Professor Ray Borrow, Public Health England, Manchester.

Panellists:
  • Prof Ziad Memish, College of Medicine, Alfaisal University & Director of Research Department
  • Dr Claire Cameron, Health Protection Scotland (2015 Scout Jamboree outbreak) 
  • Dr Philip Monk, Consultant in Health Protection and member of the UK Vaccine Preventable Invasive Bacterial Infections Forum
 
Progress and challenges in defeating neonatal meningitis and sepsis - Chair: Professor Paul Heath, St George’s University of London
  • Neonatal sepsis and meningitis in Africa
  • Cost effectiveness of GBS vaccination – Dr Caroline Trotter, University of Cambridge
  • Prospects for GBS prevention - current candidates & removing barriers to licensure of a GBS vaccine for pregnant women globally – Dr Kirsty Le Doare, Centre for International Child Health, Imperial College London and St. George’s University of London
 
15:35-16:00 TEA, EXHIBITION AND POSTERS

Current issues in diagnosis and management
  • Distinguishing bacterial and viral infections by host gene expression – Dr Jethro Herberg, Imperial College London
 
Diagnosis –possibilities for a point of care test for meningitis; Panel discussion. Chair: Prof James Stuart, University of Bristol.  
Why are we where we are today? What are the challenges – scientific/logistic/ health systems in high income and low income settings? What are the consequences for understanding burden of disease and controlling outbreaks? 

Panellists:
  • Prof Sir Brian Greenwood, LSHTM
  • Prof Enitan Carrol, University of Liverpool 
  • Dr Xin Wang, CDC WHO Meningitis Collaborating Centre
  • Dr Anne-Laure Page,  Epicentre/MSF
  • Dr Olivier Ronveaux, WHO Geneva
  • Prof Rosanna Peeling, LSHTM
  • Dr Rangarajan Sampath, FIND
 
Evening wine reception for all delegates and participants


Day 2 – Wednesday 15 November
 
  • Registration and Coffee
  • Pfizer Satellite Session Trumenba update - TBC
 
Advances from Research
  • Developments in the detection and understanding of meningococcal carriage, and implications for studies of the impact of MenB vaccines – Prof Adam Finn, University of Bristol
  • B part of it, the Australian MenB carriage study and pilot in university students Prof Helen Marshall, University of Adelaide, Australia
  • Pneumococcal prevention: lessons from whole genome sequencing - Dr Stephanie Lo, Wellcome Trust Sanger Institute, UK 
 
10:25-10:55 COFFEE, EXHIBITION AND POSTERS

Progress and challenges in defeating epidemic meningitis
  • Current situation in the meningitis belt, impact of MenAfriVac, countries that have introduced or committed to introducing it into routine schedules, catch up campaigns, controlling outbreaks and the challenge of maintaining vaccine stockpiles, use of conjugate and polysaccharide vaccines - Dr Marie Pierre Preziosi and Dr Olivier Ronveaux, World Health Organization, Geneva.
  • Progress on MenACWYX vaccine: phase 1 trial results– Dr Marc La Force, Serum Institute of India
  • Implications of epidemic pneumococcal meningitis in meningitis belt countries Prof James Stuart, University of Bristol 
 
12:10 LUNCH, EXHIBITION AND POSTERS
 
  • Poster presentations from the top 5 poster abstracts and award for the best poster (~5 minute presentations). Chair – Prof Christoph Tang, University of Oxford
 
Progress in Prevention(1)
  • Optimising pneumococcal conjugate vaccine schedules – Prof David Goldblatt, University College London
  • Effectiveness of pneumococcal conjugate vaccines in developing countries - Prof Kim Mulholland, London School of Hygiene Tropical Medicine & Murdoch Children’s Research Institute, Australia
  • Responding to MenB outbreaks in universities in the UK and the US – Dr Sema Mandal, Public Health England , London
 
15:05-15:30 COFFEE, EXHIBITION AND POSTERS

Progress in Prevention(2)
  • Impact and challenges of the MenACWY programme and catch up campaign in the UK - Helen Campbell, Public Health England, London
  • Safety and efficacy of MenB vaccination in the UK - Dr Shamez Ladhani, Public Health England, London
  • Immunogenicity of a reduced 4CMenB vaccine schedule in healthy infants and those at increased risk of meningococcal disease - Dr Matthew Snape, Oxford Vaccine Group
  • Impact of MenZB on the incidence of gonorrhoea and potential future implications for cost effectiveness of teenage meningococcal vaccination - Dr Janine Paynter, University of Auckland, New Zealand
 
17.05 - CLOSE
A.
  • Professor Ray Borrow, PHE
  • Professor Ian Feavers, NIBSC
  • Professor Adam Finn, University of Bristol
  • Professor Sir Brian Greenwood, LSHTM
  • Professor George Griffin, SGUL
  • Professor Paul Heath, SGUL
  • Professor Rob Heyderman, UCL
  • Professor Nigel Klein, Great Ormond Street/UCL
  • Dr Simon Nadel, St Mary’s Hospital / Imperial College London
  • Dr Mary Ramsay, PHE
  • Professor James Stuart, London School of Hygiene Tropical Medicine
  • Dr Matthew Snape, Oxford Vaccine Group
  • Professor Christoph Tang, University of Oxford
  • Dr Caroline Trotter, University of Cambridge
  • Linda Glennie, Meningitis Research Foundation

This conference is made possible thanks to the support of our sponsors:

Headline sponsors:

The conference is also supported by:
 

Share this
Ways You Can Help

Please do what you can today and help save and change the lives of thousands